-transparent.png){kind=logo}
AT III is a physiologic inhibitor of blood clot formation: its deficiency is manifested by venous thrombosis. The authors reported case of mesenteric venous infarction in a 42-years-old woman. AT III deficiency was transient and caused by an oral contraceptive. In patients with AT III acquired deficiency it is necessary to suppress any risk factors of venous thrombosis.
Related Publications
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
January 1996,
Annales de chirurgie,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
January 1988,
Archives of pathology & laboratory medicine,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
June 1975,
Annals of surgery,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
August 1987,
Journal of clinical pathology,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
July 1992,
Angiology,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
December 1981,
The American journal of gastroenterology,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
January 1986,
Cahiers d'anesthesiologie,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
September 1993,
Revue medicale de Bruxelles,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
November 1979,
JAMA,
M Miguil, and
C el Kettani, and
S Salmi, and
A Benslama, and
A Abdelouafi, and
O Abbassi
January 1988,
The Veterinary clinics of North America. Small animal practice,
